Seema Sethi

4.6k total citations
90 papers, 3.1k citations indexed

About

Seema Sethi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Seema Sethi has authored 90 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 29 papers in Cancer Research and 28 papers in Oncology. Recurrent topics in Seema Sethi's work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (11 papers) and Lung Cancer Treatments and Mutations (11 papers). Seema Sethi is often cited by papers focused on MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (11 papers) and Lung Cancer Treatments and Mutations (11 papers). Seema Sethi collaborates with scholars based in United States, India and China. Seema Sethi's co-authors include Fazlul H. Sarkar, Aamir Ahmad, Dejuan Kong, Wei Chen, Sanjeev Banerjee, Shadan Ali, Yiwei Li, Amro Aboukameel, Zhiwei Wang and Yiwei Li and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Seema Sethi

87 papers receiving 3.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Seema Sethi	1.9k	1.2k	957	614	271	90	3.1k
Sichuan Xi	2.0k 1.1×	754 0.6×	1.4k 1.5×	568 0.9×	129 0.5×	55	3.2k
Weiyi Fang	2.9k 1.5×	1.8k 1.4×	1.0k 1.1×	470 0.8×	601 2.2×	138	4.5k
Ken A. Olaussen	1.8k 1.0×	835 0.7×	1.7k 1.8×	1.5k 2.5×	348 1.3×	55	3.7k
Odilia Popanda	1.7k 0.9×	775 0.6×	577 0.6×	340 0.6×	132 0.5×	72	2.5k
Lynn Cawkwell	1.3k 0.7×	763 0.6×	890 0.9×	404 0.7×	339 1.3×	90	2.6k
Chao Chen	1.4k 0.7×	996 0.8×	817 0.9×	320 0.5×	158 0.6×	130	2.7k
Nils Brünner	1.2k 0.6×	972 0.8×	1.0k 1.1×	322 0.5×	165 0.6×	96	2.4k
Lidong Wang	1.6k 0.9×	589 0.5×	783 0.8×	497 0.8×	934 3.4×	113	2.8k
H. Peter Rodemann	1.8k 1.0×	560 0.4×	979 1.0×	663 1.1×	140 0.5×	56	3.0k

Countries citing papers authored by Seema Sethi

Since Specialization

Citations

This map shows the geographic impact of Seema Sethi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seema Sethi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seema Sethi more than expected).

Fields of papers citing papers by Seema Sethi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seema Sethi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seema Sethi. The network helps show where Seema Sethi may publish in the future.

Co-authorship network of co-authors of Seema Sethi

This figure shows the co-authorship network connecting the top 25 collaborators of Seema Sethi. A scholar is included among the top collaborators of Seema Sethi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seema Sethi. Seema Sethi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Eric Xueyu, Rozita Abdul Malik, Yu‐Li Su, et al.. (2026). Amivantamab plus FOLFOX or FOLFIRI in RAS/BRAF wild-type metastatic colorectal cancer: Long-term follow-up from the phase 1b/2 OrigAMI-1 study.. Journal of Clinical Oncology. 44(2_suppl). 166–166.

Kim, Yoon Jun, SH Lee, B. Liu, et al.. (2025). 4O: Amivantamab plus lazertinib vs osimertinib in first-line (1L) EGFR-mutant (EGFRm) advanced NSCLC: Final overall survival (OS) from the phase III MARIPOSA study. Journal of Thoracic Oncology. 20(3). S6–S8. 14 indexed citations

Tobi, Martin, Seema Sethi, Harvinder Talwar, et al.. (2024). Predicting Regression of Barrett’s Esophagus—Can All the King’s Men Put It Together Again?. Biomolecules. 14(9). 1182–1182. 2 indexed citations

Cho, Byoung Chul, Enriqueta Felip, Hidetoshi Hayashi, et al.. (2021). MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer. Future Oncology. 18(6). 639–647. 63 indexed citations

Sethi, Seema, Seema Sethi, Sajiv Sethi, Sajiv Sethi, & Martin H. Bluth. (2018). Clinical Implication of MicroRNAs in Molecular Pathology. Clinics in Laboratory Medicine. 38(2). 237–251. 19 indexed citations

Sethi, Seema, et al.. (2018). Myelolipoma of the Pelvis: A Case Report and Review of Literature. Frontiers in Oncology. 8. 251–251. 6 indexed citations

Michelhaugh, Sharon K., Neil V. Klinger, Prahlad Parajuli, et al.. (2015). Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1. Journal of Translational Medicine. 13(1). 227–227. 12 indexed citations

Yin, Shuping, Liping Xu, R. Daniel Bonfil, et al.. (2013). Tumor-Initiating Cells and FZD8 Play a Major Role in Drug Resistance in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 12(4). 491–498. 54 indexed citations

Hassan, Oudai, Aamir Ahmad, Seema Sethi, & Fazlul H. Sarkar. (2012). Recent updates on the role of microRNAs in prostate cancer. Journal of Hematology & Oncology. 5(1). 9–9. 63 indexed citations

10.

Wang, Guohui, Gang Liu, Xiaogang Wang, et al.. (2012). ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways. BMC Cancer. 12(1). 225–225. 33 indexed citations

11.

Bao, Bin, Shadan Ali, Aamir Ahmad, et al.. (2012). Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment. PLoS ONE. 7(12). e50165–e50165. 134 indexed citations

12.

Zhang, Haijun, Fanyan Meng, Bas Kreike, et al.. (2011). Engagement of I-Branching β-1, 6- N -Acetylglucosaminyltransferase 2 in Breast Cancer Metastasis and TGF-β Signaling. Cancer Research. 71(14). 4846–4856. 70 indexed citations

13.

Sethi, Seema, Rouba Ali‐Fehmi, Silvia Franceschi, et al.. (2011). Characteristics and survival of head and neck cancer by HPV status: a cancer registry‐based study. International Journal of Cancer. 131(5). 1179–1186. 83 indexed citations

14.

Hillman, Gilda G., Vinita Singh‐Gupta, Christopher K. Yunker, et al.. (2011). Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury. Radiotherapy and Oncology. 101(2). 329–336. 35 indexed citations

15.

Meng, Fanyan, Haijun Zhang, Gang Liu, et al.. (2011). p38γ Mitogen-Activated Protein Kinase Contributes to Oncogenic Properties Maintenance and Resistance to Poly (ADP-Ribose)-Polymerase-1 Inhibition in Breast Cancer. Neoplasia. 13(5). 472–IN25. 43 indexed citations

16.

Parajuli, Prahlad, Nirmal Joshee, Sreenivasa R. Chinni, et al.. (2010). Delayed growth of glioma by Scutellaria flavonoids involve inhibition of Akt, GSK-3 and NF-κB signaling. Journal of Neuro-Oncology. 101(1). 15–24. 35 indexed citations

17.

Sethi, Seema, et al.. (2009). Noninvasive Molecular Detection of Head and Neck Squamous Cell Carcinoma. Diagnostic Molecular Pathology. 18(2). 81–87. 27 indexed citations

18.

Sardana, Kabir, et al.. (2003). Spontaneously Improving Michelin Tire Baby Syndrome. Pediatric Dermatology. 20(2). 150–152. 11 indexed citations

19.

Sethi, Seema, Ricardo S. Cajulis, S. Tunc Gokaslan, Denise Frias‐Hidvegi, & Gordon H. Yu. (1997). Diagnostic significance of signet ring cells in fine-needle aspirates of the breast. Diagnostic Cytopathology. 16(2). 117–121. 10 indexed citations

20.

Sethi, Seema, et al.. (1993). Role of copper in Indian childhood cirrhosis. Annals of Tropical Paediatrics. 13(1). 3–5. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact